MedGenome closes a $4M Series A round to expand its cancer-focused genetic database
Bangalore, India-based healthtech startup MedGenome has completed a $4 million Series A funding round. Investors include Papillon Capital, Emerge Venture Lab and Angel investors. The company has created a genomic bioinformatics database that allows researchers to track cancer-related mutations. The database is available to oncologists and related healthcare professionals to allow for the linking of disease-specific characteristics to currently approved drugs and clinical trials, as well as better identification of genetic markers that may be warning signs of specific types of cancer. It was incubated out of SciGenom in 2012.